Short-term relugolix treatment for fibroid-related pain: where do we go from here?


Like Comment
Related Content

Volume 112, Issue 5, Pages 819–820


Paolo Vercellini, M.D.a,b, Giussy Barbara, M.D.a, Edgardo Somigliana, M.D.a,b


Reflections on "Relugolix. A novel oral GnRH antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo controlled, phase 3 study in Japanese women" by Osuga et al. 

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.